Use of medication for insomnia or anxiety increases mortality risk by 36 percent

September 9, 2010

Taking medications to treat insomnia and anxiety increases mortality risk by 36%, according to a study conducted by Genevičve Belleville, a professor at Universite Laval's School of Psychology. The details of this study are published in the latest edition of the Canadian Journal of Psychiatry.

Dr. Belleville arrived at these results through analysis of 12 years of data on over 14,000 Canadians in Statistics Canada's National Population Health Survey. The data includes information on the social demographics, lifestyle, and health of Canadians age 18 to 102, surveyed every two years between 1994 and 2007.

During this period, respondents who reported having used medication to treat insomnia or anxiety at least once in the month preceding the survey had a mortality rate of 15.7%. Respondents who reported not having used such medications had a rate of 10.5%. After controlling for personal factors that might affect , notably alcohol and tobacco consumption, physical health, physical activity level, and the presence or absence of depressive symptoms among participants, Dr. Belleville established that the consumption of sleeping pills or anxiety-relieving medications was associated with a 36% increase in the risk of death.

A number of hypotheses have been put forward to explain the link between use of these medications and increased mortality. Sleeping pills and anxiolytics affect reaction time, alertness, and coordination and are thus conducive to falls and other accidents. They may also have an inhibiting effect on the respiratory system, which could aggravate certain breathing problems during sleep. These medications are also central nervous system inhibitors that may affect judgment and thus increase the risk of suicide.

"These medications aren't candy, and taking them is far from harmless," commented Dr. Belleville. "Given that cognitive behavioral therapies have shown good results in treating and anxiety, doctors should systematically discuss such therapies with their patients as an option. Combining a pharmacological approach in the short term with psychological treatment is a promising strategy for reducing and promoting sleep."

Related Stories

Recommended for you

Elderly may face increased dementia risk after a disaster

October 24, 2016

Elderly people who were uprooted from damaged or destroyed homes and who lost touch with their neighbors after the 2011 tsunami in Japan were more likely to experience increased symptoms of dementia than those who were able ...

Research examines role of early-life stress in adult illness

October 24, 2016

Scientists have long known that chronic exposure to psychosocial stress early in life can lead to an increased vulnerability later in life to diseases linked to immune dysfunction and chronic inflammation, including arthritis, ...

Plan ahead for successful aging, researcher says

October 20, 2016

For many people, the prospect of aging is scary and uncomfortable, but Florida State University Assistant Professor Dawn Carr says that research reveals a few tips that can improve our chances of a long, healthy life.


Adjust slider to filter visible comments by rank

Display comments: newest first

not rated yet Sep 09, 2010
I guess people with insomnia should stick to good ol' weed
Sep 09, 2010
This comment has been removed by a moderator.

Please sign in to add a comment. Registration is free, and takes less than a minute. Read more

Click here to reset your password.
Sign in to get notified via email when new comments are made.